Every 8-K that IBEX Limited (IBEX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow IBEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IBEX filings page.
IBEX Ltd (IBEX) extended and expanded its credit facilities and reported record fiscal 2026 results with guidance for 2027. The U.S. Credit Agreement maturity was pushed to the earlier of October 22, 2029 or the Amended UAE Credit Agreement’s maturity, with a $25 million secured revolving facility subject to a 0.20% closing fee and a 0.30% annual commitment fee on the unused portion. In the UAE, Ibex Global FZ-LLC extended its facilities to October 22, 2029, kept a committed $50 million post-shipment seller revolving loan and a $50,000 credit card facility, added a $1 million performance bond facility, and granted a security interest over receivables up to $58.9 million.
For fiscal 2026, revenue rose 15.4% to $644.1 million, net income increased to $46.3 million, adjusted EBITDA to $82.4 million, and diluted EPS to $3.13, with free cash flow of $31.2 million and year-end net cash of $30.9 million. Guidance for fiscal 2027 calls for revenue of $700–$715 million and adjusted EBITDA of $90–$94 million, implying high-single to low-double-digit growth.
IBEX Limited announced that its board of directors has authorized a share repurchase program allowing the company to buy back up to $20 million of its common stock. The program begins on May 14, 2026 and may run for up to one year.
Repurchases may occur through open market purchases, privately negotiated deals, block trades, or other lawful methods, subject to market conditions and compliance with SEC Rules 10b-18 and 10b5-1. The company plans to fund repurchases using its existing cash balance and free cash flow. The board may adjust, suspend, or discontinue the program at any time, and IBEX is not obligated to repurchase a specific number of shares.
IBEX Limited reported strong results for its third fiscal quarter ended March 31, 2026 and raised full-year guidance. Revenue rose 16.8% to $164.4 million, driven by double-digit growth across HealthTech, Technology, Travel & Logistics, and Retail & E-commerce.
Net income increased to $13.3 million, with diluted EPS up 21.9% to $0.89. Adjusted EBITDA grew to $22.0 million, while free cash flow improved to $6.6 million. The company now expects fiscal 2026 revenue of $638–$642 million and adjusted EBITDA of $82–$84 million, and highlighted a new strategic AI partnership with Sierra.ai.
IBEX Limited filed a current report to share that it has released financial results for its second fiscal quarter ended December 31, 2025. On February 5, 2026, the company issued a press release detailing these quarterly results, which is included as Exhibit 99.1. The report notes that this earnings information is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
Ibex Limited (IBEX) reported that its Board of Directors has created a formal Nominating Committee made up entirely of independent directors. Previously, nominating duties were handled by the independent members of the full Board, a structure that the company notes already complied with Nasdaq rules requiring that director nominations be made solely by independent directors.
The new Nominating Committee will identify and evaluate director candidates, recommend nominees each year, and set criteria for board and committee membership, as outlined in its charter on the company’s website. The Board appointed Daniella Ballou-Aares as Chair, along with Karen Batungbacal, Fiona Beck, Patrick McGinnis, and Mingzhe (JJ) Zhuang, each determined to be independent under Nasdaq and SEC standards.
Upon formation, the Committee ratified prior actions of the independent directors and re-nominated the existing slate of director candidates for election at the annual meeting scheduled for December 5, 2025. These steps were taken in response to concerns raised by proxy advisory firms Institutional Shareholder Services and Glass Lewis about the nominating process, and the company believes the changes fully resolve those issues.
IBEX Limited filed a current report to let investors know it has released its financial results for the first fiscal quarter ended September 30, 2025. On November 6, 2025, the company issued a press release covering these quarterly results, which is included as Exhibit 99.1 to the report. The company notes that this information is being furnished, not filed, meaning it is not subject to certain liability provisions of the securities laws or automatically incorporated into other SEC filings.
IBEX Limited filed a current report to furnish its latest earnings announcement. On September 11, 2025, the company issued a press release sharing financial results for its fourth quarter and full fiscal year ended June 30, 2025. The press release, which contains the detailed numbers and commentary, is attached as Exhibit 99.1.
The company notes that this earnings information is being furnished rather than filed, which limits certain legal liabilities under securities laws. No other corporate actions or material events are described in this report beyond the release of the quarterly and full-year results.